Matches in Wikidata for { <http://www.wikidata.org/entity/Q89543350> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- Q89543350 description "article scientifique publié en 2020" @default.
- Q89543350 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89543350 description "im Februar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89543350 description "scientific article published on 05 February 2020" @default.
- Q89543350 description "wetenschappelijk artikel" @default.
- Q89543350 description "наукова стаття, опублікована 5 лютого 2020" @default.
- Q89543350 name "A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment" @default.
- Q89543350 name "A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment" @default.
- Q89543350 type Item @default.
- Q89543350 label "A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment" @default.
- Q89543350 label "A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment" @default.
- Q89543350 prefLabel "A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment" @default.
- Q89543350 prefLabel "A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment" @default.
- Q89543350 P1433 Q89543350-D9598B53-64EA-46AC-9F8E-B07BC07192D5 @default.
- Q89543350 P1476 Q89543350-2812B0B6-0A5D-4987-AB4A-91591492980F @default.
- Q89543350 P2093 Q89543350-169D88AD-A35D-4339-8A7F-D0E725BD0329 @default.
- Q89543350 P2093 Q89543350-1834B187-26E1-4D91-948B-C452C068DC4C @default.
- Q89543350 P2093 Q89543350-1E7D1258-3078-40E8-BEC4-F36D63FB3071 @default.
- Q89543350 P2093 Q89543350-3C5BFAF4-ABAC-4ED2-B06F-F5B62B3A85E7 @default.
- Q89543350 P2093 Q89543350-41ABC5F3-9DE7-4003-8C1B-539A9D6CB67C @default.
- Q89543350 P2093 Q89543350-5D8F7401-3183-4FB6-AAED-A94373DF1680 @default.
- Q89543350 P2093 Q89543350-682DD019-8D9C-45D6-98E4-0D83572EE485 @default.
- Q89543350 P2093 Q89543350-93B2AD52-7436-4D22-B6D7-11AAA2AD5B99 @default.
- Q89543350 P2093 Q89543350-97D38F4F-C18C-4A4E-A904-D6AADE74391B @default.
- Q89543350 P2093 Q89543350-C4C8C0F2-44AF-4DEF-B150-BEAFC06A80E3 @default.
- Q89543350 P2860 Q89543350-03B08C87-E94E-4D04-843A-1D34BE99F4F4 @default.
- Q89543350 P2860 Q89543350-0A4D6CCD-BFB4-4FB4-97D4-19BC8ECEE33D @default.
- Q89543350 P2860 Q89543350-0CB811A9-986B-4776-B38E-DB123785B3D7 @default.
- Q89543350 P2860 Q89543350-2B9D6B68-1D6A-4C70-9E4C-1434E7B9C66F @default.
- Q89543350 P2860 Q89543350-6D886ACD-1F25-450B-820E-DE7A011DC11A @default.
- Q89543350 P2860 Q89543350-873C0558-8D58-4FC6-894C-B67F6DAC8432 @default.
- Q89543350 P2860 Q89543350-948151FD-107C-49C7-9839-D7490414A435 @default.
- Q89543350 P2860 Q89543350-A193269C-722F-40B5-B1F5-D241C880DAC8 @default.
- Q89543350 P2860 Q89543350-BF0CB33B-4C89-4E80-BB10-942B24A420D9 @default.
- Q89543350 P2860 Q89543350-E3CD6020-06FD-4296-B3DC-FE55688F824C @default.
- Q89543350 P304 Q89543350-433916B7-00D6-43C8-9845-0DFC7BE3E23D @default.
- Q89543350 P31 Q89543350-6f69307b-eece-4b1c-a6ac-7edf9be31c22 @default.
- Q89543350 P31 Q89543350-F141E1A1-B977-4F01-ABEF-A0DF380BE619 @default.
- Q89543350 P356 Q89543350-A2512C37-BE46-46F7-859B-5F7F89C6F329 @default.
- Q89543350 P433 Q89543350-0C160B68-DCAB-4BD6-BD13-FF2055155334 @default.
- Q89543350 P478 Q89543350-835C6D48-6549-4DCA-B689-623A5310A29B @default.
- Q89543350 P50 Q89543350-37843497-34F7-477D-B4F1-3BA929131C86 @default.
- Q89543350 P577 Q89543350-EFB41F3A-38F4-4C4F-9855-7FDC6B92E516 @default.
- Q89543350 P698 Q89543350-C1E3039E-9C28-4568-A312-A8543A065407 @default.
- Q89543350 P921 Q89543350-3AEEBF2A-B29E-4C9F-B3F6-725731441F29 @default.
- Q89543350 P921 Q89543350-B5181986-0078-4D5C-AC9D-E3A9ED1FF021 @default.
- Q89543350 P932 Q89543350-EA784560-A810-487C-AF74-2ABFAE3AAD31 @default.
- Q89543350 P356 ACN3.50977 @default.
- Q89543350 P698 32022482 @default.
- Q89543350 P1433 Q27725312 @default.
- Q89543350 P1476 "A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment" @default.
- Q89543350 P2093 "Alice Veauville-Merllié" @default.
- Q89543350 P2093 "Cécile Acquaviva" @default.
- Q89543350 P2093 "François Salachas" @default.
- Q89543350 P2093 "Ghizlene Lahlou" @default.
- Q89543350 P2093 "Guillaume Fargeot" @default.
- Q89543350 P2093 "Isabelle Mosnier" @default.
- Q89543350 P2093 "Nicolas Weiss" @default.
- Q89543350 P2093 "Sophie Demeret" @default.
- Q89543350 P2093 "Timothée Lenglet" @default.
- Q89543350 P2093 "Yann Nadjar" @default.
- Q89543350 P2860 Q24633696 @default.
- Q89543350 P2860 Q37037611 @default.
- Q89543350 P2860 Q39100335 @default.
- Q89543350 P2860 Q47623812 @default.
- Q89543350 P2860 Q48167886 @default.
- Q89543350 P2860 Q48431125 @default.
- Q89543350 P2860 Q50353700 @default.
- Q89543350 P2860 Q50430326 @default.
- Q89543350 P2860 Q50432448 @default.
- Q89543350 P2860 Q91821909 @default.
- Q89543350 P304 "250-253" @default.
- Q89543350 P31 Q13442814 @default.
- Q89543350 P31 Q2782326 @default.
- Q89543350 P356 "10.1002/ACN3.50977" @default.
- Q89543350 P433 "2" @default.
- Q89543350 P478 "7" @default.
- Q89543350 P50 Q89543347 @default.
- Q89543350 P577 "2020-02-05T00:00:00Z" @default.
- Q89543350 P698 "32022482" @default.
- Q89543350 P921 Q130365 @default.
- Q89543350 P921 Q206901 @default.
- Q89543350 P932 "7034506" @default.